Loading organizations...
Loading organizations...
Oncology-focused biopharmaceutical company developing cancer therapies.
Arcus Biosciences has raised $497.0M across 3 funding rounds.
Arcus Biosciences has raised $497.0M in total across 3 funding rounds.
Arcus Biosciences has raised $497.0M in total across 3 funding rounds.
Arcus Biosciences's investors include Merdad Parsey, Google Ventures, Aisling Capital, BVF Partners, Celgene, Decheng Capital, Droia Ventures, EcoR1 Capital, Foresite Capital, Hillhouse Capital Group, Invus Opportunities, Leerink Partners.
Arcus Biosciences has raised $497.0M across 3 funding rounds. Most recently, it raised $320.0M Other Equity in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 30, 2024 | $320.0M Other Equity | Merdad Parsey | |
| Nov 13, 2017 | $107.0M Series C | Google Ventures | Aisling Capital, BVF Partners, Celgene, Decheng Capital, Droia Ventures, EcoR1 Capital, Foresite Capital, Hillhouse Capital Group, Invus Opportunities, Leerink Partners, Taiho Ventures, The Column Group, Wellington Management |
| Sep 1, 2016 | $70.0M Series B | Celgene, Droia Ventures, Foresite Capital, Google Ventures, Invus, Novartis, Stanford University, Taiho Ventures, The Column Group |